Loading ...

Michele DesMarais

Immune Tolerance Network

Associate Director, Clinical Operations

Assessment Group

mdesmarais@immunetolerance.org

Work:

415-420-4250

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

Gray Circle Icon

ITN004ST

-

Gray Circle Icon

ITN005CT

-

Islet Transplantation for Type 1 Diabetes

Gray Circle Icon

ITN008ST

-

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Gray Circle Icon

ITN009ST

-

Gray Circle Icon

ITN010ST

-

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Gray Circle Icon

ITN013ST

-

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

Gray Circle Icon

ITN014CT

-

Gray Circle Icon

ITN015CT

-

Gray Circle Icon

ITN022ST

-

Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

Gray Circle Icon

ITN023ST

-

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

Gray Circle Icon

ITN024ST

-

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

Gray Circle Icon

ITN029ST

-

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

Gray Circle Icon

ITN030ST

-

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

Gray Circle Icon

ITN036ST

-

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

Gray Circle Icon

ITN039ST

-

Research Study of ATG and Rituximab in Renal Transplantation

Gray Circle Icon

ITN040CT

-

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

Gray Circle Icon

ITN054ST

-

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

Gray Circle Icon

ITN056ST

-

Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

Gray Circle Icon

ITN062ST

-

Tolerance by engaging antigen during cellular homeostasis

Gray Circle Icon

ITN063ST

-

A Cohort Study of Operationally Tolerant Allograft Recipients

Gray Circle Icon

ITN069ST

-

Renal Allograft Tolerance Through Mixed Chimerism And Co-Stimulation Blockade With Belatacept

Gray Circle Icon

ITN073ST

-

Liver Transplantation with Tregs at MGH

Gray Circle Icon

ITN074ST

-

Liver Transplantation with Tregs at UCSF

Gray Circle Icon

ITN085AI

-

Autologous Regulatory T Cell Therapy for Autoimmune Hepatitis

Gray Circle Icon

ITN089ST

-

Carfilzomib and Belatacept for Desensitization

Gray Circle Icon

ITN090ST

-

Daratumumab and Belatacept for Desensitization

Gray Circle Icon

ITN101ST

-

EVR and EPO for Liver Transplant Tolerance

Gray Circle Icon

ITN501ST

-

Thomson Tolerance Correlates off Immunosuppression

Gray Circle Icon

ITN503ST

-

GAMBIT: Assays indicative of tolerance

Gray Circle Icon

ITN507ST

-

Study of Tolerant Kidney Transplant Recipients

Gray Circle Icon

ITN524ST-CTOT-12

-

Associating Renal Transplantation With the ITN Signature of Tolerance

Gray Circle Icon

ITN803ST

-

Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

Gray Circle Icon

ITN816AS

-

A Screening Study for Identification of Tolerance Markers in Liver Transplant Recipients Who Received Campath-1H Immunosuppression

Gray Circle Icon

ITN823ST

-

Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients

Gray Circle Icon

ITN828ST

-

Bio:

Admin Links

Shortcuts

ITN Documents

Links